GET DAILY SIGNALSRYTHM, Inc. (RYM) Delivers Strong Q3 Turnaround With Revenue Surge
Key Takeaways
- Revenue reached $23.86 million for the third quarter ended September 30, 2026, up from $4.04 million in the year-ago period.
- Net loss narrowed sharply to $0.53 million, or $0.07 per share, versus a loss of $10.67 million, or $5.33 per share, a year earlier.
- Operating income from continuing operations turned positive at $0.98 million, compared with an operating loss of $8.89 million in the prior-year quarter.
- Adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization) was $5.9 million, and the company generated $6.3 million in cash from operations, ending the quarter with $48.2 million in cash.
- THC (tetrahydrocannabinol) beverage depletions rose roughly 15% sequentially to an annualized 320,000 cases, while retail distribution expanded to about 8,000 doors across 18 states.
- The company did not provide formal guidance for the fourth quarter of 2026.
- For additional context on this ticker's Major News, Today's Price Move, Price Targets, and Forecast, explore the dedicated pages for RYTHM, Inc. (RYM).
- Discover Trending AI Robots to see AI-driven trading strategies actively scanning the market.
Why These Results Matter
RYTHM, Inc. (RYM) has shifted focus to become a hemp-derived THC and cannabis-brand licensing business, describing itself as "America's THC Company." The latest quarter offers a useful checkpoint on whether its beverage and edibles brands can turn wider distribution into real revenue and eventual profits. Growth has been rapid from a low base a year ago, and the key question is whether operating losses keep shrinking as the business scales. Because much of the model rests on licensing with Green Thumb Industries and hemp-derived THC products, these numbers also give a read on how the broader U.S. cannabis and hemp space is developing ahead of potential federal changes. I checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Breaking Down the Reported Numbers
For the third quarter ended September 30, 2026, RYM posted revenue of $23.86 million, up roughly 490% from $4.04 million a year earlier. Gross profit rose to $18.35 million from $1.38 million, keeping gross margins comfortably above 75%. Operating income from continuing operations reached $0.98 million, a clear improvement from the $8.89 million operating loss in the same quarter last year. After other items, the net loss came in at $0.53 million, or $0.07 per basic and diluted share, compared with a $10.67 million loss, or $5.33 per share, a year ago. Adjusted EBITDA was $5.9 million, slightly below the prior quarter’s $6.4 million.
Over the first nine months, revenue totaled $60.16 million versus $6.62 million last year, and the company recorded net income of $20.57 million that included a deferred tax benefit. Management noted a 15% sequential rise in beverage depletions to an annualized 320,000 cases and a retail presence of roughly 8,000 doors in 18 states. Cash and equivalents stood at $48.2 million at quarter-end, supported by $6.3 million in operating cash flow.
Market Reaction and Investor Focus
Shares had already been volatile ahead of the release and sat well below the 52-week high amid uncertainty around hemp-derived THC rules and possible federal shifts. After the November 4, 2026 report, attention turned to the fast revenue growth, much narrower losses, and stronger cash balance, balanced against the lack of forward guidance and questions around potential dilution. The company showed about 2.2 million shares outstanding plus 11.2 million warrants and additional shares tied to convertible notes, figures investors continue to track. Sentiment looks measured but positive, with eyes now on whether momentum holds into 2027. From what I see, the capital structure remains an area worth watching closely.
What Investors Should Monitor Next
Looking ahead, several areas stand out. Beverage depletions and retail expansion will be important signals, with the company at an annualized 320,000 cases and about 8,000 doors. Continued sequential gains would point to steady consumer demand. Regulatory developments around hemp-derived THC also matter, as management has flagged upcoming federal changes that could affect both licensing and retail sales. Capital structure and any dilution from warrants or notes remain relevant for per-share metrics. Finally, cash generation and the durability of positive operating income will be key, especially since no fourth-quarter guidance was issued.
Integrating Tickeron’s AI Tools Into Research
When reviewing names like this, I often run quick screens to compare performance and patterns across the sector. Tickeron’s AI tools help surface context without replacing the core fundamental work. In this case, they offered a useful way to benchmark RYM against peers and spot any emerging technical signals worth noting.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
RYM's RSI Indicator ascends from oversold territory
The RSI Oscillator for RYM moved out of oversold territory on October 26, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 39 similar instances when the indicator left oversold territory. In 34 of the 39 cases the stock moved higher. This puts the odds of a move higher at 87%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 63 of 76 cases where RYM's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 83%.
The Momentum Indicator moved above the 0 level on November 04, 2026. You may want to consider a long position or call options on RYM as a result. In 71 of 85 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 84%.
The Moving Average Convergence Divergence (MACD) for RYM just turned positive on October 29, 2026. Looking at past instances where RYM's MACD turned positive, the stock continued to rise in 34 of 43 cases over the following month. The odds of a continued upward trend are 79%.
Following a +10.18% 3-day Advance, the price is estimated to grow further. Considering data from situations where RYM advanced for three days, in 180 of 222 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.
Bearish Trend Analysis
The 10-day moving average for RYM crossed bearishly below the 50-day moving average on October 02, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 7 of 9 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 78%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where RYM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
RYM broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for RYM entered a downward trend on November 03, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 17 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 33 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.883) is normal, around the industry mean (-7.297). P/E Ratio (-1.511) is within average values for comparable stocks, (12.512). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.595). Dividend Yield (0.000) settles around the average of (0.060) among similar stocks. P/S Ratio (1.490) is also within normal values, averaging (2.780).
The Tickeron Price Growth Rating for this company is 81 (best 1 - 100 worst), indicating slightly worse than average price growth. RYM’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RYM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 68, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
Industry Tobacco
Advertisement